NASDAQ:SRTA Strata Critical Medical (SRTA) Stock Price, News & Analysis $5.28 -0.38 (-6.78%) As of 12:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Strata Critical Medical Stock (NASDAQ:SRTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SRTA alerts:Sign Up Key Stats Today's Range$5.28▼$5.6150-Day Range N/A52-Week Range$3.31▼$6.02Volume615,587 shsAverage Volume834,724 shsMarket Capitalization$458.96 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingModerate Buy Company Overview Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York. Read More Strata Critical Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreSRTA MarketRank™: Strata Critical Medical scored higher than 48% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingStrata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.Upside PotentialStrata Critical Medical has a consensus price target of $8.00, representing about 41.3% upside from its current price of $5.66.Amount of Analyst CoverageStrata Critical Medical has only been the subject of 4 research reports in the past 90 days.Read more about Strata Critical Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Critical Medical is -37.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Critical Medical has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.70% of the float of Strata Critical Medical has been sold short.Short Interest Ratio / Days to CoverStrata Critical Medical has a short interest ratio ("days to cover") of 9.45.Change versus previous monthShort interest in Strata Critical Medical has recently increased by 8.31%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Critical Medical does not currently pay a dividend.Dividend GrowthStrata Critical Medical does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.24 News SentimentStrata Critical Medical has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Transportation, Communications, Electric, Gas, And Sanitary Services companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Strata Critical Medical this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for SRTA on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.MarketBeat Follows1 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Critical Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Strata Critical Medical's insider trading history. Receive SRTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Critical Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTA Stock News HeadlinesStrata Critical Medical, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesMay 8, 2026 | finance.yahoo.comStrata Critical Medical, Inc. Q1 2026 Earnings Call SummaryMay 8, 2026 | finance.yahoo.comRise of the… petroyuan?On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in every five barrels of oil on Earth. Since then, 11.7 million barrels have moved completely outside the U.S. dollar clearing network. Foreign central bank Treasury holdings just hit their lowest level since 2012, with $82 billion dumped in three weeks. With $9 trillion in U.S. debt due for refinancing in the next 12 months and fewer buyers, gold analyst Garrett Goggin, CFA, CMT sees miners still priced for $1,800 gold as the overlooked opportunity before a major repricing.May 12 at 1:00 AM | Golden Portfolio (Ad)Strata Critical Medical Announces Expiration of WarrantsMay 7, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Strata Critical Medical (SRTA) and Cytokinetics (CYTK)May 7, 2026 | theglobeandmail.comStrata Critical Medical, Inc: Strata Critical Medical Announces First Quarter 2026 ResultsMay 6, 2026 | finanznachrichten.deStrata Critical Medical Announces First Quarter 2026 ResultsMay 6, 2026 | globenewswire.comStrata Acquires Ohio Valley Perfusion AssociatesApril 30, 2026 | globenewswire.comSee More Headlines SRTA Stock Analysis - Frequently Asked Questions How have SRTA shares performed this year? Strata Critical Medical's stock was trading at $4.38 at the start of the year. Since then, SRTA stock has increased by 29.2% and is now trading at $5.66. How were Strata Critical Medical's earnings last quarter? Strata Critical Medical (NASDAQ:SRTA) announced its earnings results on Wednesday, May, 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.07. The company earned $67.38 million during the quarter. Strata Critical Medical had a negative trailing twelve-month return on equity of 4.06% and a net margin of 20.56%. Who are Strata Critical Medical's major shareholders? Strata Critical Medical's top institutional investors include Sumitomo Mitsui Trust Group Inc. (1.90%), Amova Asset Management Americas Inc. (1.90%), Dimensional Fund Advisors LP (1.86%) and Bank of New York Mellon Corp (1.24%). How do I buy shares of Strata Critical Medical? Shares of SRTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2026Today5/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 4 weeks, SRTA's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTransportation, Communications, Electric, Gas, And Sanitary Services Industry Air Transportation Sub-IndustryTransportation Current SymbolNASDAQ:SRTA CIK1779128 WebN/A Phone(212) 967-1009FaxN/AEmployees130Year FoundedN/APrice Target and Rating Average Price Target for Strata Critical Medical$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+51.1%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$41.35 million Net Margins20.56% Pretax Margin-7.02% Return on Equity-4.06% Return on Assets-3.49% Debt Debt-to-Equity RatioN/A Current Ratio5.93 Quick Ratio5.93 Sales & Book Value Annual Sales$197.14 million Price / Sales2.34 Cash FlowN/A Price / Cash FlowN/A Book Value$3.22 per share Price / Book1.64Miscellaneous Outstanding Shares86,990,000Free Float73,506,000Market Cap$460.61 million OptionableN/A Beta2.15 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:SRTA) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredYale just did the math (you owe Washington $1,500)The Yale Budget Lab calculated that current U.S. trade policy is costing the average American household betwee...Priority Gold | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredIs $24 trillion about to move?Bloomberg reports that S-P Dow Jones Indices is considering rule changes that could fast-track SpaceX into the...The Oxford Club | SponsoredSpaceX Launches Strange 'Dark Energy' Across AmericaSpaceX is deploying a newly permitted energy technology - one that analyst Joel Litman calls 'Dark Energy' - t...Altimetry | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredIran broke the petrodollar…For 50 years, every barrel of oil settled in dollars - that rule is what made the dollar the world's reserve c...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Critical Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Critical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
